Ajan Reginald Biography

Ajan Reginald is a hugely accomplished and widely recognised expert in the fields of Science and Medicine. Ajan Reginald co-founded Cell Therapy Ltd (CTL) in 2009 with Professor Sir Martin Evans, Nobel Laureate 2007 and CTL is an award winning biotech company developing stem cell therapeutics with clinical programs.

CTL (Cell Therapy Limited) develops cellular medicines to treat life threatening and life altering diseases and is currently focused on CVS indications: Heart Failure and Myocardial infarction. Prior to this Ajan Reginald was Global Head of Emerging Technologies at Roche Pharmaceuticals in which he led efforts to identify and commercialise the best breakthrough life science technologies including a focus on Stem cells. Before Emerging Technologies,

Ajan completed over 30 licensing and acquisition transactions a Business Development Director at Roche. From 2003-2005 Ajan worked with the Boston Consulting Group in the USA & Zurich as a member of both the Life Sciences Practice Area and Intellectual Property Group. Ajan is a Fulbright scholar, a graduate of London Hospital School of Medicine and Dentistry and holds an MBA from the Kellogg Business School at Northwestern University. Ajan enjoys spending time with his wife and young son and in his spare time he plays competitive Hockey, representing England at the over 40’s level.